Christine Fox

Chief Financial OfficeratMereo BioPharma Group· In proxies 2022–2025

Pay in FY2025-10% from the year before · Mereo BioPharma Group stock -88.1% the same year

Christine Fox was paid $1.1M in FY2025 (Dec), down 10%. Mereo BioPharma Group stock fell 88.1% that year.

Pay$100 in the stock at the end of FY21 → $26

Pay is from the Summary Compensation Table of each Mereo BioPharma Group proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

MREO
Mereo BioPharma GroupPublic company · 4 yr
- Chief Financial Officer2022 – Present · 4 yrStock in role -81%

Roles come from the proxy statements of each company.

Activity

Pay
Mereo BioPharma Group CFO pay fell 10% to $1.1M. The stock fell 88% in FY2025 (Dec).
DEF 14AApr 9, 2026
Pay
Mereo BioPharma Group CFO pay rose 26% to $1.3M. The stock rose 52% in FY2024 (Dec).
DEF 14AApr 8, 2025
Pay
Mereo BioPharma Group CFO pay rose 23% to $1.0M. The stock rose 208% in FY2023 (Dec).
DEF 14AApr 24, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?